$INSM
Market Cap:
$13.48 Billion
Financial Snapshot
Revenue
$343.0M
TTM
Gross Margin
77.24%
TTM
Net Earnings
-$864.3M
TTM
Current Ratio
636.54%
Q3 2024
Book Value
$483.4M
Q3 2024
P/E
-15.60
Nov 29, 2024 EST
Free Cash Flow
-$451.4M
TTM
Revenues
Revenues
Loading...
Loading...
Revenue YoY Change
Loading...
Loading...
Revenues
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.2M | $245.4M | $188.5M | $164.4M | $136.5M | $9.835M | $0.00 | $0.00 | $0.00 | $0.00 | $11.50M | $0.00 | $4.417M | $6.900M | $10.40M | $11.70M | $7.600M | $1.000M | $100.0K | $100.0K | $200.0K | $2.000M | $300.0K | $100.0K | $0.00 | $0.00 |
| YoY Change | 24.39% | 30.19% | 14.63% | 20.48% | 1287.56% | -100.0% | -100.0% | -35.99% | -33.65% | -11.11% | 53.95% | 660.0% | 900.0% | 0.0% | -50.0% | -90.0% | 566.67% | 200.0% |
Expenses
Cost Of Revenues
Loading...
Loading...
Gross Profit
Loading...
Loading...
Gross Profit Margin
Loading...
Loading...
Gross Profit
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.2M | $245.4M | $188.5M | $164.4M | $136.5M | $9.835M | $0.00 | $0.00 | $0.00 | $0.00 | $11.50M | $0.00 | $4.417M | $6.900M | $10.40M | $11.70M | $7.600M | $1.000M | $100.0K | $100.0K | $200.0K | $2.000M | $300.0K | $100.0K | $0.00 | $0.00 |
| Cost Of Revenue | $65.57M | $55.13M | $44.15M | $39.87M | $24.21M | $2.423M | $0.00 | $0.00 | $0.00 | $0.00 | $600.0K | $1.500M | $0.00 | $0.00 | ||||||||||||
| Gross Profit | $239.6M | $190.2M | $144.3M | $124.5M | $112.3M | $7.412M | $0.00 | $0.00 | $10.40M | $11.70M | $7.000M | -$500.0K | $100.0K | $100.0K | ||||||||||||
| Gross Profit Margin | 78.52% | 77.53% | 76.57% | 75.75% | 82.26% | 75.36% | 100.0% | 100.0% | 92.11% | -50.0% | 100.0% | 100.0% |
Selling, General & Admin Expense
Loading...
Loading...
Research & Development
Loading...
Loading...
Depreciation, Depletion & Amortization
Loading...
Loading...
SGA Expense to Gross Profit Ratio
Loading...
Loading...
R&D To Gross Profit Ratio
Loading...
Loading...
DDA To Gross Profit Ratio
Loading...
Loading...
Operating Expenses Total
Loading...
Loading...
Operating Profits/Loss
Loading...
Loading...
Operational Expenses
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | $344.5M | $265.8M | $234.3M | $203.6M | $210.8M | $168.2M | $79.20M | $50.70M | $43.20M | $31.10M | $22.20M | $12.70M | $11.50M | $10.30M | $9.800M | $5.100M | $8.200M | $25.70M | $5.700M | $4.200M | $3.600M | $3.000M | $5.000M | $9.600M | $2.500M | $1.600M |
| YoY Change | 29.62% | 13.45% | 15.07% | -3.42% | 25.33% | 112.37% | 56.21% | 17.36% | 38.91% | 40.09% | 74.8% | 10.43% | 11.65% | 5.1% | 92.16% | -37.8% | -68.09% | 350.88% | 35.71% | 16.67% | 20.0% | -40.0% | -47.92% | 284.0% | 56.25% | 60.0% |
| % of Gross Profit | 143.76% | 139.72% | 162.34% | 163.48% | 187.79% | 2269.29% | 94.23% | 43.59% | 117.14% | 5700.0% | 4200.0% | |||||||||||||||
| Research & Development | $571.0M | $397.5M | $272.7M | $181.2M | $131.7M | $145.3M | $109.7M | $122.7M | $74.28M | $56.30M | $44.28M | $29.78M | $28.62M | $4.700M | $9.200M | $21.00M | $19.20M | $21.10M | $21.80M | $23.30M | $7.100M | $18.10M | $35.50M | $21.60M | $5.700M | $3.700M |
| YoY Change | 43.64% | 45.75% | 50.56% | 37.54% | -9.34% | 32.38% | -10.57% | 65.22% | 31.93% | 27.15% | 48.68% | 4.05% | 509.0% | -48.91% | -56.19% | 9.38% | -9.0% | -3.21% | -6.44% | 228.17% | -60.77% | -49.01% | 64.35% | 278.95% | 54.05% | 42.31% |
| % of Gross Profit | 238.28% | 208.96% | 189.0% | 145.46% | 117.33% | 1960.11% | 88.46% | 179.49% | 274.29% | 21800.0% | 23300.0% | |||||||||||||||
| Depreciation & Amortization | $5.500M | $5.300M | $9.100M | $9.100M | $5.200M | $3.600M | $2.900M | $2.400M | $1.982M | $1.070M | $680.0K | $561.0K | $343.0K | $50.00K | $710.0K | $1.040M | $410.0K | $3.370M | $12.90M | $30.00K | $100.0K | $350.0K | $1.550M | $790.0K | $90.00K | $80.00K |
| YoY Change | 3.77% | -41.76% | 0.0% | 75.0% | 44.44% | 24.14% | 20.83% | 21.09% | 85.23% | 57.35% | 21.21% | 63.56% | 586.0% | -92.96% | -31.73% | 153.66% | -87.83% | -73.88% | 42900.0% | -70.0% | -71.43% | -77.42% | 96.2% | 777.78% | 12.5% | 33.33% |
| % of Gross Profit | 2.3% | 2.79% | 6.31% | 7.31% | 4.63% | 48.57% | 6.83% | 8.89% | 5.86% | 12900.0% | 30.0% | |||||||||||||||
| Operating Expenses | $571.0M | $397.5M | $272.7M | $181.2M | $131.7M | $145.3M | $188.9M | $173.4M | $117.5M | $87.40M | $66.52M | $42.44M | $66.14M | $15.00M | $19.00M | $26.10M | $27.40M | $46.80M | $27.60M | $27.50M | $10.70M | $21.10M | $40.50M | $31.20M | $8.100M | $5.300M |
| YoY Change | 43.64% | 45.75% | 50.56% | 37.54% | -9.34% | -23.1% | 8.95% | 47.58% | 34.43% | 31.4% | 56.73% | -35.83% | 340.91% | -21.05% | -27.2% | -4.74% | -41.45% | 69.57% | 0.36% | 157.01% | -49.29% | -47.9% | 29.81% | 285.19% | 52.83% | 47.22% |
| Operating Profit | -$709.6M | -$457.3M | -$375.1M | -$265.2M | -$235.2M | -$307.3M | -$188.9M | -$173.4M | -$117.5M | -$55.02M | -$42.44M | -$61.72M | -$8.600M | -$14.40M | -$20.40M | -$47.30M | -$27.50M | -$27.40M | ||||||||
| YoY Change | 55.17% | 21.92% | 41.42% | 12.75% | -23.46% | 62.68% | 8.95% | 47.58% | 29.64% | -31.24% | -40.28% | -29.41% | -56.87% | 72.0% | 0.36% |
Interest Expenses
Loading...
Loading...
Interest Expenses To Operating Income %
Loading...
Loading...
Other Expense/Income
Loading...
Loading...
Interest & Other Expense/Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $81.69M | $26.45M | $40.47M | $29.56M | $27.71M | $25.47M | $5.925M | $3.498M | $2.889M | -$2.400M | $2.412M | $763.0K | $10.00K | $1.700M | $0.00 | -$1.300M | $500.0K | -$1.800M | -$13.50M | $200.0K | $300.0K | $600.0K | $3.000M | $1.900M | $300.0K | $500.0K |
| YoY Change | 208.91% | -34.66% | 36.9% | 6.71% | 8.77% | 329.91% | 69.38% | 21.08% | -220.38% | -199.5% | 216.12% | 7530.0% | -99.41% | -100.0% | -360.0% | -127.78% | -86.67% | -6850.0% | -33.33% | -50.0% | -80.0% | 57.89% | 533.33% | -40.0% | 400.0% | |
| % of Operating Profit | ||||||||||||||||||||||||||
| Other Income/Expense, Net | $1.856M | -$5.939M | -$3.330M | $405.0K | -$531.0K | $602.0K | $300.0K | $119.0K | -$33.00K | $100.0K | -$33.00K | $5.000K | $1.000K | $0.00 | $127.5M | $0.00 | $0.00 | |||||||||
| YoY Change | -131.25% | 78.35% | -922.22% | -176.27% | -188.21% | 100.67% | 152.1% | -460.61% | -133.0% | -403.03% | -760.0% | 400.0% | -100.0% |
Income/Loss
Pretax Income
Loading...
Loading...
Income Tax
Loading...
Loading...
Net Profits/Loss
Loading...
Loading...
Pretax Income YoY Change
Loading...
Loading...
Income Tax Rate
Loading...
Loading...
Net Profits/Loss YoY Change
Loading...
Loading...
Basic EPS
Loading...
Loading...
Net Income To Revenue Ratio
Loading...
Loading...
Pretax & Net Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretax Income | -$747.0M | -$480.2M | -$436.4M | -$292.7M | -$253.6M | -$324.1M | -$192.9M | -$176.2M | -$120.2M | -$89.60M | -$57.29M | -$41.37M | -$59.66M | -$6.400M | $118.8M | -$15.70M | -$20.00M | -$56.10M | -$40.90M | -$27.20M | -$10.30M | -$36.40M | -$37.20M | -$79.70M | -$7.800M | -$4.800M |
| YoY Change | 55.58% | 10.02% | 49.1% | 15.43% | -21.76% | 67.98% | 9.51% | 46.62% | 34.1% | 56.39% | 38.48% | -30.66% | 832.25% | -105.39% | -856.69% | -21.5% | -64.35% | 37.16% | 50.37% | 164.08% | -71.7% | -2.15% | -53.32% | 921.79% | 62.5% | 37.14% |
| Income Tax | $2.555M | $1.383M | -$1.758M | $1.402M | $777.0K | $201.0K | -$272.0K | $98.00K | -$1.971M | -$10.40M | -$1.221M | $0.00 | $0.00 | $100.0K | $500.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $200.0K | $0.00 | $0.00 |
| % Of Pretax Income | 0.42% | |||||||||||||||||||||||||
| Net Earnings | -$749.6M | -$481.5M | -$434.7M | -$294.1M | -$254.3M | -$324.3M | -$192.6M | -$176.3M | -$118.2M | -$79.20M | -$56.07M | -$41.37M | -$59.66M | -$6.400M | $118.4M | -$15.70M | -$20.00M | -$56.10M | -$40.90M | -$27.20M | -$10.30M | -$36.40M | -$37.20M | -$79.90M | -$7.800M | -$4.800M |
| YoY Change | 55.66% | 10.79% | 47.8% | 15.63% | -21.57% | 68.33% | 9.29% | 49.15% | 49.22% | 41.24% | 35.53% | -30.66% | 832.25% | -105.41% | -854.14% | -21.5% | -64.35% | 37.16% | 50.37% | 164.08% | -71.7% | -2.15% | -53.44% | 924.36% | 62.5% | 37.14% |
| Net Earnings / Revenue | -245.59% | -196.26% | -230.63% | -178.87% | -186.37% | -3297.17% | -487.59% | -1350.78% | -92.75% | 1138.46% | -134.19% | -263.16% | -5610.0% | -40900.0% | -27200.0% | -5150.0% | -1820.0% | -12400.0% | -79900.0% | |||||||
| Basic Earnings Per Share | -$5.34 | -$3.91 | -$3.88 | -$3.01 | -$3.01 | |||||||||||||||||||||
| Diluted Earnings Per Share | -$5.34 | -$3.91 | -$3.88 | -$3.01 | -$3.01 | -$4.217M | -$2.892M | -$2.848M | -$2.017M | -$1.838M | -$1.603M | -$1.562M | -$2.562M | -$48.30K | $9.323M | -$1.287M | -$1.739M | -$5.905M | -$8.347M | -$6.974M | -$2.861M | -$11.03M | -$11.27M | -$44.39M | -$26.00M | -$16.00M |
Assets & Liabilities
Cash & Short-Term Investments
Loading...
Loading...
Cash & Equivalents
Loading...
Loading...
Cash To Operating Expenses Ratio
Loading...
Loading...
Inventory
Loading...
Loading...
Receivables
Loading...
Loading...
Total Short-Term Assets
Loading...
Loading...
Property, Plant And Equipment
Loading...
Loading...
Long-Term Investments
Loading...
Loading...
Total Long-Term Assets
Loading...
Loading...
Total Assets
Loading...
Loading...
Net Income To Total Assets Percentage
Loading...
Loading...
Accounts Payable
Loading...
Loading...
Short-Term Debt
Loading...
Loading...
Long Term Debt Due
Loading...
Loading...
Total Short-Term Liabilities
Loading...
Loading...
Long-Term Debt
Loading...
Loading...
Other Long-Term Liabilities
Loading...
Loading...
Total Long-Term Liabilities
Loading...
Loading...
Total Liabilities
Loading...
Loading...
Short-Term To Long-Term Debt Ratio
Loading...
Loading...
Short-Term Assets To Debt Ratio
Loading...
Loading...
Long-Term Debt To Net Income Ratio
Loading...
Loading...
Assets & Liabilities
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Short-Term Investments | $780.4M | $1.148B | $716.8M | $532.8M | $487.4M | $495.1M | $381.2M | $162.6M | $282.9M | $159.2M | $113.9M | $92.90M | $76.30M | $108.0M | $122.2M | $2.400M | $16.50M | $24.10M | $18.80M | $9.200M | $29.50M | $27.30M | $51.30M | $83.10M | $4.600M | $11.70M |
| YoY Change | -32.03% | 60.2% | 34.53% | 9.31% | -1.56% | 29.88% | 134.44% | -42.52% | 77.7% | 39.77% | 22.6% | 21.76% | -29.35% | -11.62% | 4991.67% | -85.45% | -31.54% | 28.19% | 104.35% | -68.81% | 8.06% | -46.78% | -38.27% | 1706.52% | -60.68% | |
| Cash & Equivalents | $482.4M | $1.074B | $716.8M | $532.8M | $487.4M | $495.1M | $381.2M | $162.6M | $282.9M | $159.2M | $113.9M | $92.90M | $14.80M | $10.70M | $12.70M | $2.100M | $16.50M | $24.10M | $18.80M | $9.200M | $29.50M | $27.30M | $51.30M | $71.60M | $300.0K | $11.70M |
| Short-Term Investments | $298.1M | $74.24M | $0.00 | $61.40M | $97.30M | $109.4M | $300.0K | $0.00 | $11.50M | $4.300M | $0.00 | |||||||||||||||
| Other Short-Term Assets | $24.18M | $25.47M | $28.90M | $24.00M | $20.20M | $11.30M | $8.300M | $5.800M | $5.200M | $5.500M | $2.300M | $600.0K | $400.0K | $300.0K | $200.0K | $100.0K | $200.0K | $500.0K | $400.0K | $500.0K | $200.0K | $600.0K | $300.0K | $300.0K | $0.00 | $0.00 |
| YoY Change | -5.06% | -11.87% | 20.41% | 18.81% | 78.76% | 36.14% | 43.1% | 11.54% | -5.45% | 139.13% | 283.33% | 50.0% | 33.33% | 50.0% | 100.0% | -50.0% | -60.0% | 25.0% | -20.0% | 150.0% | -66.67% | 100.0% | 0.0% | |||
| Inventory | $83.25M | $69.92M | $67.01M | $49.60M | $28.30M | $7.000M | $0.00 | $600.0K | $0.00 | |||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||||||||
| Receivables | $41.19M | $29.71M | $24.35M | $16.60M | $19.20M | $5.500M | $0.00 | $800.0K | $500.0K | $200.0K | $100.0K | $300.0K | $200.0K | $0.00 | ||||||||||||
| Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.100M | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Total Short-Term Assets | $929.1M | $1.273B | $837.0M | $622.9M | $555.2M | $518.9M | $389.4M | $168.4M | $288.1M | $164.7M | $116.2M | $93.60M | $77.40M | $108.8M | $124.6M | $2.600M | $17.00M | $25.40M | $19.20M | $9.700M | $29.80M | $28.20M | $55.00M | $84.60M | $4.700M | $11.70M |
| YoY Change | -27.04% | 52.13% | 34.38% | 12.19% | 7.0% | 33.26% | 131.24% | -41.55% | 74.92% | 41.74% | 24.15% | 20.93% | -28.86% | -12.68% | 4692.31% | -84.71% | -33.07% | 32.29% | 97.94% | -67.45% | 5.67% | -48.73% | -34.99% | 1700.0% | -59.83% | |
| Property, Plant & Equipment | $104.4M | $102.1M | $95.52M | $97.20M | $113.1M | $22.60M | $12.40M | $10.00M | $8.100M | $7.500M | $1.800M | $1.700M | $1.900M | $1.100M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $200.0K | $1.200M | $1.600M | $200.0K | $200.0K | |
| YoY Change | 2.26% | 6.87% | -1.73% | -14.06% | 400.44% | 82.26% | 24.0% | 23.46% | 8.0% | 316.67% | 5.88% | -10.53% | 72.73% | -100.0% | -50.0% | -83.33% | -25.0% | 700.0% | 0.0% | |||||||
| Goodwill | ||||||||||||||||||||||||||
| YoY Change | ||||||||||||||||||||||||||
| Intangibles | ||||||||||||||||||||||||||
| YoY Change | ||||||||||||||||||||||||||
| Long-Term Investments | $0.00 | $50.04M | $0.00 | $2.100M | $2.200M | $2.100M | $0.00 | $300.0K | $0.00 | |||||||||||||||||
| YoY Change | -100.0% | -100.0% | -4.55% | 4.76% | -100.0% | |||||||||||||||||||||
| Other Assets | $96.57M | $76.10M | $50.99M | $26.80M | $20.30M | $4.300M | $2.000M | $1.300M | $2.100M | $400.0K | $300.0K | $100.0K | $200.0K | $0.00 | $0.00 | $2.200M | $2.300M | $2.900M | $3.700M | $3.300M | $0.00 | $0.00 | $300.0K | $400.0K | $0.00 | |
| YoY Change | 26.9% | 49.25% | 90.26% | 32.02% | 372.09% | 115.0% | 53.85% | -38.1% | 425.0% | 33.33% | 200.0% | -50.0% | -100.0% | -4.35% | -20.69% | -21.62% | 12.12% | -100.0% | -25.0% | |||||||
| Total Long-Term Assets | $400.8M | $383.1M | $406.5M | $173.3M | $187.1M | $85.70M | $72.60M | $69.60M | $68.50M | $66.20M | $60.30M | $60.00M | $62.40M | $87.50M | $2.100M | $2.200M | $2.500M | $2.900M | $3.700M | $3.300M | $0.00 | $100.0K | $16.60M | $18.10M | $600.0K | $200.0K |
| YoY Change | 4.63% | -5.76% | 134.55% | -7.38% | 118.32% | 18.04% | 4.31% | 1.61% | 3.47% | 9.78% | 0.5% | -3.85% | -28.69% | 4066.67% | -4.55% | -12.0% | -13.79% | -21.62% | 12.12% | -100.0% | -99.4% | -8.29% | 2916.67% | 200.0% | ||
| Total Assets | $1.330B | $1.656B | $1.244B | $796.2M | $742.3M | $604.6M | $462.0M | $238.0M | $356.6M | $230.9M | $176.5M | $153.6M | $139.8M | $196.3M | $126.7M | $4.800M | $19.50M | $28.30M | $22.90M | $13.00M | $29.80M | $28.30M | $71.60M | $102.7M | $5.300M | $11.90M |
| YoY Change | ||||||||||||||||||||||||||
| Accounts Payable | $68.74M | $52.61M | $35.78M | $42.90M | $13.20M | $17.70M | $14.70M | $10.40M | $7.500M | $9.200M | $5.900M | $7.100M | $2.300M | $1.500M | $300.0K | $1.300M | $900.0K | $7.200M | $1.000M | $2.600M | $700.0K | $900.0K | $4.400M | $2.600M | $700.0K | $200.0K |
| YoY Change | 30.66% | 47.02% | -16.59% | 225.0% | -25.42% | 20.41% | 41.35% | 38.67% | -18.48% | 55.93% | -16.9% | 208.7% | 53.33% | 400.0% | -76.92% | 44.44% | -87.5% | 620.0% | -61.54% | 271.43% | -22.22% | -79.55% | 69.23% | 271.43% | 250.0% | |
| Accrued Expenses | $154.3M | $136.4M | $98.77M | $74.90M | $70.60M | $60.50M | $29.30M | $16.80M | $11.00M | $10.00M | $7.100M | $5.400M | $1.900M | $1.300M | $1.700M | $1.400M | $1.200M | $2.400M | $3.600M | $2.100M | $2.000M | $2.600M | $5.700M | $1.400M | $100.0K | |
| YoY Change | 13.09% | 38.11% | 31.87% | 6.09% | 16.69% | 106.48% | 74.4% | 52.73% | 10.0% | 40.85% | 31.48% | 184.21% | 46.15% | -23.53% | 21.43% | 16.67% | -50.0% | -33.33% | 71.43% | 5.0% | -23.08% | -54.39% | 307.14% | 1300.0% | ||
| Deferred Revenue | ||||||||||||||||||||||||||
| YoY Change | ||||||||||||||||||||||||||
| Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| YoY Change | ||||||||||||||||||||||||||
| Long-Term Debt Due | $2.610M | $1.217M | $609.0K | $1.100M | $1.200M | $0.00 | $3.100M | $0.00 | $3.300M | $3.100M | $100.0K | $100.0K | $200.0K | $1.600M | $1.300M | $0.00 | ||||||||||
| YoY Change | 114.46% | 99.84% | -44.64% | -8.33% | -100.0% | -100.0% | 6.45% | 3000.0% | 0.0% | -50.0% | -87.5% | 23.08% | ||||||||||||||
| Total Short-Term Liabilities | $225.6M | $190.2M | $135.2M | $118.8M | $85.20M | $79.70M | $44.70M | $28.00M | $22.30M | $19.60M | $16.50M | $15.70M | $4.500M | $3.300M | $2.800M | $4.900M | $3.700M | $9.700M | $4.900M | $5.000M | $2.900M | $3.900M | $10.30M | $4.100M | $800.0K | $300.0K |
| YoY Change | 18.6% | 40.75% | 13.78% | 39.44% | 6.9% | 78.3% | 59.64% | 25.56% | 13.78% | 18.79% | 5.1% | 248.89% | 36.36% | 17.86% | -42.86% | 32.43% | -61.86% | 97.96% | -2.0% | 72.41% | -25.64% | -62.14% | 151.22% | 412.5% | 166.67% | |
| Long-Term Debt | $1.182B | $1.155B | $580.7M | $371.0M | $355.5M | $316.6M | $55.60M | $54.80M | $22.00M | $24.90M | $16.30M | $16.30M | $200.0K | $100.0K | $0.00 | $500.0K | $2.100M | $3.200M | $6.400M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| YoY Change | 2.38% | 98.88% | 56.52% | 4.36% | 12.29% | 469.42% | 1.46% | 149.09% | -11.65% | 52.76% | 0.0% | 8050.0% | 100.0% | -100.0% | -76.19% | -34.38% | -50.0% | |||||||||
| Other Long-Term Liabilities | $253.8M | $223.4M | $117.2M | $30.40M | $39.90M | $0.00 | $800.0K | $700.0K | $600.0K | $100.0K | $400.0K | $600.0K | $900.0K | $0.00 | $2.200M | $2.200M | $1.600M | $1.000M | $700.0K | $600.0K | $1.000M | $1.700M | $1.800M | $0.00 | ||
| YoY Change | 13.63% | 90.6% | 285.47% | -23.81% | -100.0% | 14.29% | 16.67% | 500.0% | -75.0% | -33.33% | -33.33% | -100.0% | 0.0% | 37.5% | 60.0% | 42.86% | 16.67% | -40.0% | -41.18% | -5.56% | ||||||
| Total Long-Term Liabilities | $1.436B | $1.378B | $697.9M | $401.4M | $395.4M | $316.6M | $56.40M | $55.50M | $22.60M | $25.00M | $16.70M | $16.90M | $1.100M | $100.0K | $0.00 | $2.700M | $4.300M | $4.800M | $7.400M | $700.0K | $600.0K | $1.000M | $1.700M | $1.800M | $0.00 | $0.00 |
| YoY Change | 4.2% | 97.49% | 73.86% | 1.52% | 24.89% | 461.35% | 1.62% | 145.58% | -9.6% | 49.7% | -1.18% | 1436.36% | 1000.0% | -100.0% | -37.21% | -10.42% | -35.14% | 957.14% | 16.67% | -40.0% | -41.18% | -5.56% | ||||
| Total Liabilities | $1.662B | $1.568B | $833.0M | $520.3M | $480.6M | $396.3M | $101.0M | $83.50M | $44.90M | $44.60M | $33.20M | $32.70M | $5.600M | $3.400M | $2.800M | $7.600M | $8.000M | $14.50M | $12.30M | $5.800M | $3.600M | $4.900M | $11.90M | $5.900M | $800.0K | $300.0K |
| YoY Change | 5.95% | 88.28% | 60.11% | 8.26% | 21.27% | 292.38% | 20.96% | 85.97% | 0.67% | 34.34% | 1.53% | 483.93% | 64.71% | 21.43% | -63.16% | -5.0% | -44.83% | 17.89% | 112.07% | 61.11% | -26.53% | -58.82% | 101.69% | 637.5% | 166.67% |
Ownership
Basic Shares Outstanding
Loading...
Loading...
Diluted Shares Outstanding
Loading...
Loading...
Preferred Stock
Loading...
Loading...
Treasury Stock Shares
Loading...
Loading...
Stock Issuance & Repurchase
Loading...
Loading...
Ownership Data
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basic Shares Outstanding | 140.4M shares | 123.0M shares | 112.1M shares | 97.61M shares | 84.56M shares | 76.89M shares | 66.58M shares | 61.89M shares | 58.63M shares | 43.10M | 34.98M shares | 26.55M shares | 23.35M shares | |||||||||||||
| Diluted Shares Outstanding | 140.4M shares | 123.0M shares | 112.1M shares | 97.61M shares | 84.56M shares | 76.89M shares | 66.58M shares | 61.89M shares | 58.63M shares | 34.98M shares | 26.55M shares | 23.35M shares | ||||||||||||||
| Preferred Stock | ||||||||||||||||||||||||||
| Treasury Stock Shares |
Return On Shareholders' Equity
Loading...
Loading...
Book Value
Loading...
Loading...
Free Cash Flow
Loading...
Loading...
Free Cash Flow YoY
Loading...
Loading...
Free Cash Flow Margin
Loading...
Loading...
Dividends
Dividends
Loading...
Loading...
Stock Price
Loading...
Market Cap: $13.482 Billion
About INSMED Inc
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. The company is headquartered in Bridgewater, New Jersey and currently employs 912 full-time employees. The firm's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Industry: Pharmaceutical Preparations Peers: ACADIA PHARMACEUTICALS INC AMICUS THERAPEUTICS, INC. ARROWHEAD PHARMACEUTICALS, INC. BIOCRYST PHARMACEUTICALS INC Denali Therapeutics Inc. Relay Therapeutics, Inc. Sage Therapeutics, Inc. Ultragenyx Pharmaceutical Inc. Vir Biotechnology, Inc.
